Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
5 studies found for:    SSR149744C or celivarone�
Show Display Options
Rank Status Study
1 Completed Double Blind Placebo COntrolled Dose Ranging studY of the eFficacy and safEty of SSR149744c 300 or 600 mg for the Conversion of Atrial Fibrillation / fluttEr
Conditions: Atrial Fibrillation;   Atrial Flutter
Intervention: Drug: CELIVARONE (SSR149744C)
2 Completed Placebo Controlled Double-blind Dose Ranging Study of the Efficacy and Safety of SSR149744C 50, 100, 200 or 300 mg OD With Amiodarone as Calibrator for the Maintenance of Sinus Rhythm in Patients With Recent Atrial Fibrillation/Flutter
Conditions: Atrial Fibrillation;   Atrial Flutter
Intervention: Drug: CELIVARONE (SSR149744C)
3 Completed Double Blind Placebo Controlled Dose Ranging Study of the Efficacy and Safety of SSR149744c 100 or 300 mg for the Prevention of ventrICular ARrhythmia-triggered Icd interventiOnS
Conditions: Arrhythmia;   Tachycardia, Ventricular;   Ventricular Fibrillation
Intervention: Drug: SSR149744C
4 Completed Dose Ranging Study of Celivarone With Amiodarone as Calibrator for the Prevention of Implantable Cardioverter Defibrillator (ICD) Interventions or Death
Conditions: Arrhythmia Prophylaxis;   Ventricular Arrhythmia
Interventions: Drug: Celivarone;   Drug: Amiodarone;   Drug: Matching placebo
5 Completed Efficacy and Safety Study of an Antiarrhythmic Drug to Treat Atrial Fibrillation in Patients With Pacemakers
Condition: Atrial Fibrillation
Interventions: Drug: ATI-2042;   Drug: ATI-2042 200 mg

Study has passed its completion date and status has not been verified in more than two years.